Agencia Nacional de Promocion Cientifica y Tecnica, Argentina Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2009
NCT01729663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4